LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹4.85 Cr | ₹2.24 Cr | ₹5.91 Cr | ₹7.82 Cr | ₹-3.17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LASA SUPERGENERICS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹4.85 Cr |
Mar2023 | ₹2.24 Cr |
Mar2022 | ₹5.91 Cr |
Mar2021 | ₹7.82 Cr |
Mar2020 | ₹-3.17 Cr |
How is Deferred Tax Assets / Liabilities of LASA SUPERGENERICS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.85 Cr | 116.91 | |
Mar2023 | ₹2.24 Cr | -62.20 | |
Mar2022 | ₹5.91 Cr | -24.42 | |
Mar2021 | ₹7.82 Cr | Positive | |
Mar2020 | ₹-3.17 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹61.4 Cr | -3.9% | 0.8% | -48.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -3.9% |
0.8% |
-48.6% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses